(Q83177898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Mohammad Reza Safarinejad

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

20 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Impotence Research

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

550-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625231%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901476

19 January 2020

exact match

0 references

cites work

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Sildenafil in erectile dysfunction: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

When an erection alone is not enough: biopsychosocial obstacles to lovemaking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

A study using Viagra in a mental health practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Central neural regulation of penile erection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Molecular diversity of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Structures of dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Mental symptoms in Parkinsonian patients treated with L-dopa.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Sexual Behavior During L-dopa Treatment for Parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Opposite influence of medial preoptic D1 and D2 receptors on genital reflexes: implications for copulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Clinical experience with apomorphine hydrochloride: the first 107 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Ergoline derivatives: receptor affinity and selectivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Behavioral studies on LEK-8804, a new ergoline derivative with potent 5-HT1A receptor agonist and 5-HT2 receptor antagonist activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Mechanism of the antihypertensive effect of FCE 22716, a new ergoline derivative, in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Structure-activity study of some newly synthesized ergoline derivatives on 5-HT2 receptors and alpha-adrenoceptors in rabbit isolated aorta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

An open clinical trial of fluoxetine in the treatment of premature ejaculation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Agonism at 5-HT2B receptors is not a class effect of the ergolines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

1 reference

7 January 2021

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Salvage of sildenafil failures referred from primary care physicians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Outcome Analysis of Goal Directed Therapy for Impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Influence of cause on choice of therapy in 174 patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Hormone-neurotransmitter interactions in the control of sexual behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Neurobiological correlates of masculine sexual behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Sexual behavior induction of c-Fos in the nucleus accumbens and amphetamine-stimulated locomotor activity are sensitized by previous sexual experience in female Syrian hamsters.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Functions of dopamine in the dorsal and ventral striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Effects of acute prolactin manipulation on sexual drive and function in males

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Shortening of the interoestrous interval and the lifespan of the corpus luteum of the cyclic dog by bromocryptine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Bromocriptine-induced premature oestrus is associated with changes in the pulsatile secretion pattern of follicle-stimulating hormone in beagle bitches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Cabergoline in Parkinson's disease: long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Indications and early results of sildenafil (Viagra) in erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Serum leptin levels in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021

Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901476

7 January 2021